According to the research report titled ‘Global Injectable Drugs Market (2021 Edition) - Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)’, available with Market Study Report LLC, global injectable drugs market was assessed at USD 414.88 billion in 2020 and is projected to showcase lucrative growth between 2021-2026.
 

Rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders like multiple sclerosis and rheumatoid arthritis, and growing demand for drug delivery systems are the key growth stimulants for global injectable drugs market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855666/
 

Furthermore, increasing preference for self-administered injectable formulations such as needle-free injectors, auto injectors, pre-filled syringes, and pen injectors have also boosted demand for injectable drugs.  
 

While rising demand for injectables in vaccines, and large molecule peptides will facilate industry growth, patent expiries, drug shortages, pricing pressures, and regulatory challenges will act as challenges for businesses in this domain.
 

Based on molecule type, large molecule segment is speculated to grow rapidly between 2021-2026, owing to surging prevalence of chronic diseases such as cancer and diabetes, coupled with increasing geriatric populace. 
 

Regionally speaking, North America currently holds a major share in global injectable drugs market, primarily due to the development of modern healthcare infrastructure, heavy investments in R&D, and presence of leading players across the region. Rising adoption of oncology-related drugs to treat different cancers is also aiding revenue inflow.
 

Meanwhile, Asia Pacific market is projected to witness considerable growth between 2021-2026, owing to formulation of new drugs which have low permeability, and are less soluble in water, thus enabling adequate absorption in the gastrointestinal tract following oral administration.
 

Leading players influencing global injectable drugs market dynamics are Pfizer Inc., Sanofi S.A., Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Company, Novartis International AG, AstraZeneca plc, Merck KGaA, Baxter International Inc., and Novo Nordisk A/S.